Skip to content

NgenIRS

Completed

NgenIRS is a four year partnership (2016-2019), led by IVCC and funded by Unitaid, that includes the US President’s Malaria Initiative, the Global Fund, Abt Associates and PATH.

The market shaping intervention project has $65.1 million funding and works in close collaboration with leading insecticide manufacturers, national malaria programmes and other stakeholders to increase the use of 3rd Generation Indoor Residual Spraying (3GIRS) products. This is done by supporting insecticide resistance and management strategies throughout Africa.

Project Aims

NgenIRS is establishing a sustainable, competitive and growing market for effective 3GIRS products at affordable prices.

We are making the most effective, long lasting insecticides available to malaria programmes and implementation partners to support insecticide resistance management strategies.

To achieve this we are addressing key barriers to Access through market shaping interventions:

  • Demand: accelerating uptake of 3GIRS products.
  • Market Stability: improving global forecasts for 3GIRS products.
  • Competition and IRM: facilitating the introduction of competition with new quality-assured products from several manufacturers.
  • Affordability: reducing 3GIRS prices through co-payments, reliable and guaranteed forecasts.

Funding partner

Unitaid

Industry partners

Clinton health
MedAccess Trust
UKaid
Unitaid
USAID

NgenIRS - the evidence (2020)

Due to the NgenIRS project the downward trend in IRS use was reversed and the resulting expansion of use has resulted in significant public health impact, savings in commodity costs and new evidence showing the cost-effectiveness of 3GIRS.

NgenIRS evidence

Below are the project overview and evidence slide decks (in English and French) from the four-year project.

NgenIRS project overview

Download

NgenIRS evidence: English slides

Download

NgenIRS evidence: French slides

Download

NgenIRS - behind the Project

IVCC’s Next Generation Indoor Residual Spraying (IRS) project is making a major difference in Africa. This video explains the strategy behind the project.

Related projects

Registered office: Liverpool School Of Tropical Medicine, Pembroke Place, Liverpool, Merseyside, L3 5QA.

Registered in England and Wales
Company number: 06719882
Phone: +44 151 705 3268

Useful

Policies

Back To Top
No results found...